Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 164

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 164
---
 options that are not In-the-Money STAAR Options. |

| (4) | Includes vested restricted stock awards or units subject to deferred delivery, as follows: 
 Mr. Jiang—1,061 shares and Mr. Farrell – 921 shares.                                       |

| (5) | Based on 49,696,096 shares of common stock outstanding on the stock records as of August 25, 2025. The                                                                                                                                     
 percentages are calculated in accordance with Rule 13d-3(d)(1), which provides that shares not outstanding that are subject to options, warrants, rights or conversion privileges exercisable on or before                                 
 October 24, 2025 (60 days after August 25, 2025) are deemed outstanding for the purpose of calculating the number and percentage that each person owns, but not deemed outstanding for the purpose of calculating the percentage which any 
 other listed person owns.                                                                                                                                                                                                                  |

-101-

FUTURE STOCKHOLDER PROPOSALS

If the Merger is completed, STAAR will have no public stockholders and there will be no public participation in any future meetings of STAAR
stockholders. However, if the Merger is not completed, STAAR stockholders will continue to be entitled to attend and participate in stockholder meetings.

STAAR will hold an annual meeting of stockholders in 2026 (the “2026 Annual Meeting”) only if the Merger has not already been
completed and STAAR remains a public company.

A stockholder who intends to nominate a candidate for election to the Board or to propose
any business for presentation at the 2026 Annual Meeting, in the event such a meeting is held, pursuant to the advance notice provisions of STAAR’s bylaws must timely submit notice thereof in writing to STAAR’s Corporate Secretary at
STAAR’s principal executive offices at Office of the Corporate Secretary, STAAR Surgical Company, 25510 Commercentre Drive, Lake Forest, California, 92630. In order to be timely, the stockholder must provide such written notice not earlier
than the 120th day and not later than the 90th day prior to the first anniversary of the preceding year’s annual meeting (no earlier than February 18, 2026, and no later than March 20, 2026); provided, however, that in the event that
the date of the annual meeting is more than 30 days before or more than 70 days after such anniversary date, notice by the stockholder must be so delivered